Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
[Combination treatment in pulmonary arterial hypertension].
Mordechai R. Kramer
*
*
Corresponding author for this work
Rabin Medical Center Israel
Research output
:
Contribution to journal
›
Review article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of '[Combination treatment in pulmonary arterial hypertension].'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pulmonary Arterial Hypertension
100%
Combination Treatment
100%
Treatment Options
50%
Combination Therapy
50%
Effective Treatment
25%
Drug Class
25%
Severe Disease
25%
Synergistic Effect
25%
Malignancy
25%
Treatment Choice
25%
Hypertension Management
25%
Congestive Heart Failure
25%
Severe Cases
25%
Oral Therapy
25%
Patient Survival
25%
Targeted Therapy
25%
Combination of Therapies
25%
Sildenafil
25%
Bosentan
25%
NewHope
25%
Prostanoids
25%
Treatment Algorithm
25%
Iloprost
25%
Endothelin Receptor Antagonist
25%
Treprostinil
25%
International Clinical Trials
25%
Ambrisentan
25%
Intravenous Prostanoid
25%
PDE5 Inhibitors
25%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
100%
Combination Therapy
50%
Clinical Trial
25%
Congestive Heart Failure
25%
Prostaglandin
25%
Prostacyclin
25%
Bosentan
25%
Iloprost
25%
Endothelin Receptor Antagonist
25%
Sildenafil
25%
Treprostinil
25%
Phosphodiesterase V Inhibitor
25%
Ambrisentan
25%
Diseases
25%